The Egyptian medical industry achieved significant growth during 2025, reaching an 18% increase in production value compared to the previous year.
According to the Chamber's latest industry report, production value across pharmaceuticals, medical devices and supplements rose 18% year-over-year.
Growth was driven by capacity expansions, import substitution programmes and stronger demand from regional markets.
Egyptian pharmaceutical companies signed new export agreements with international partners across the Gulf, Africa and Europe, worth over $150 million.
Read more
The Ministry of Health issued new GMP guidelines to enhance quality standards and support local manufacturers in meeting international requirements.
Read more
Egyptian cosmetics exports increased by 22% during the first quarter, reaching new markets in Latin America and Asia.
Read more